Eva Barnett
Net worth: 11 M $ as of 31/05/2026
Net worth: 11 M $ as of 31/05/2026
Eva Renee Barnett formerly worked at Immunovant, Inc., as Chief Financial & Accounting Officer from 2021 to 2025, Eli Lilly & Co., as Chief Financial Officer-Austria & Switzerland from 2011 to 2012, and AbleTo, Inc., as Chief Integration Officer in 2021.
Ms. Barnett received her undergraduate degree from DePauw University and Masters Business Admin degree from Harvard Business School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOVANT INC 0.16% | 13/06/2025 | 327,119 ( 0.16% ) | 11 M $ | 31/05/2026 |
| Companies | Position | End |
|---|---|---|
| IMMUNOVANT, INC. | Director of Finance/CFO | 20/04/2025 |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Director of Finance/CFO | 01/03/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/08/2012 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Health Services |
DePauw University
DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions